Favorable remission induction rate with twice weekly doses of L-asparaginase.
D000005:Abdomen; D000293:Adolescent; D001215:Asparaginase / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D001856:Bone Marrow Examination; D002648:Child; D002675:Child, Preschool; D003371:Cough / Q000139:chemically induced; D003490:Cyanosis / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004926:Escherichia coli; D005334:Fever / Q000139:chemically induced; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D007958:Leukocyte Count; D009325:Nausea / Q000139:chemically induced; D010146:Pain / Q000139:chemically induced; D012075:Remission, Spontaneous; D014839:Vomiting / Q000139:chemically induced
D001215:Asparaginase